Housing planned for Novartis U.K. site; sterile drug market to hit $70B by 2018;

> Contract manufacturer Vetter is now offering clinical syringe packages that it claims will simplify the process of syringe development. Release

> SHL Pharma, which makes drug delivery systems, will invest $6 million into the renovation and expansion of its manufacturing and R&D facility in Deerfield Beach, FL. Release

> Sterile injectable drugs is a $60 billion a year market slated to grow another $10 billion through 2018. Report

> A surge in industrial production in the U.K. was underpinned by pharmaceutical manufacturing. Report

And Finally... Novartis ($NVS) will sell some of the land at its Horsham, U.K. R&D site for housing and look for other potential uses for the campus, which will close at year's end. Story